The STC Autonomous Nervous System and Safety Studies was founded in 2004 expressly for the coordination of the clinical pilot-study with a subretinal implant.

Clinical Pilot Study Retina Implant

A prospective open pilot study with functional placebo-control to evaluate the efficacy and tolerability of a subretinal implant in blind patients.

Description

This is the first clinical study in humans with a subretinal implant.

Patient groups

Blind patients with hereditary retinal degenerations

Organisation and Coordination of the Study

PD Dr. med. Barbara Wilhelm and Tobias Peters

Informationen

• Study Information (German)
• Study Information (English)

Sponsors

• Retina Implant AG
• BMBF (German Federal Ministry of Education and Research)

Partners in Research and Development

• AMTech (www.amtech.de)
• Boehringer Ingelheim (Pharmaton) (www.pharmaton.com)
• DaimlerChrysler (www.daimlerchrysler.com)
• Multi Channel Systems (www.multichannelsystems.com)
• Plusoptix (www.plusoptix.de)
• Bayerisches Staatsministerium für Umwelt, Gesundheit und Verbraucherschutz (www.stmugv.bayern.de)
• Acucela (www.acucela.com)
• Pfizer (www.pfizer.com)
• European Vision Institute. (www.europeanvisioninstitute.org/CT_SE)

---

Head: PD Dr. med. Barbara Wilhelm

Deputy Head: Tobias Peters